Zhiqiang Sun

机构：Bozhou People's Hospital, Southern Medical University Shenzhen Hospital

发表论文 67 篇 · 总被引 1352 次 · h-index 19

代表论文

Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial (2023 · Journal of Hematology & Oncology · 被引 72)
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia (2022 · Journal of Internal Medicine · 被引 44)
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD : A multicenter phase 2 study (2023 · Journal of Internal Medicine · 被引 22)
Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies (2023 · Frontiers in Oncology · 被引 10)
Chinese guidelines for integrated diagnosis and treatment of intestinal microecology technologies in tumor application (2024 Edition) (2024 · Journal of Cancer Research and Therapeutics · 被引 8)
Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate‐risk acute myeloid leukemia in first complete remission undergoing auto‐HSCT : An open‐label, multicenter, randomized phase 3 trial (2023 · American Journal of Hematology · 被引 7)